Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes

Sarah Gilligan1, Kalani L Raphael1

  • 1Division of Nephrology, Department of Medicine, University of Utah, Salt Lake City, UT; and Nephrology Section, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT.

Insights

Serum potassium abnormalities, including hyperkalemia and hypokalemia, are common in chronic kidney disease (CKD). Both conditions increase risks for death and cardiovascular disease, with hypokalemia potentially worsening CKD progression.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Cardiology

Background:

  • Serum potassium abnormalities are frequent in patients with chronic kidney disease (CKD).
  • Hyperkalemia is a recognized complication, but hypokalemia occurs with similar prevalence (12%-18%) compared to hyperkalemia (14%-20%).

Purpose of the Study:

  • To review the prevalence and risk factors for hyperkalemia and hypokalemia in CKD patients.
  • To examine the associations between these potassium imbalances and adverse outcomes in CKD.

Main Methods:

  • Literature review of studies on serum potassium levels in CKD.
  • Analysis of factors influencing serum potassium, including CKD severity, medications (RAAS inhibitors, diuretics), and diet.
  • Evaluation of associations with mortality, cardiovascular disease, hospitalization, and CKD progression.

Main Results:

  • Both hyperkalemia and hypokalemia are linked to increased risks of death, cardiovascular disease, and hospitalization.
  • Limited evidence suggests hypokalemia, but not hyperkalemia, may be associated with CKD progression.

Conclusions:

  • Serum potassium monitoring and management are crucial in CKD patients due to similar prevalence of hyperkalemia and hypokalemia.
  • Both conditions carry significant risks, highlighting the need for comprehensive patient assessment and intervention strategies.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...